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1. Introduction 
The cardiac risk (CR) in noncardiac surgery represents the probability of acute 
cardiovascular conditions appearance, assessed as perioperative complications. 
The most frequent perioperative complications are the acute manifestations of coronary or 
noncoronary ischemia; acute or exacerbated chronic heart failure (CHF); acute rhythm and 
conductive disorders; acute cardiac inflammatory processes; increased arterial blood 
pressure or hypertensive crisis; cardiogenic shock and sudden cardiac death. These 
conditions are either early signs, or represent a manifestation of progress or decompensation 
of present cardiac diseases. Specific indication may be found in their origin, if it is explicitly 
or implicitly associated with the present surgical disease or with a completed surgical 
intervention, giving weight to the special features of the perioperative period [1].  
The major surgical interventions, e.g. in the thoracic cavity and the upper abdominal cavity, 
as well as the neurosurgical and the major orthopedic operations, are related to increased 
CR. Previous myocardial infarction, unstable stenocardia and decompressed chronic cardiac 
insufficiency are powerful predictors for the emergence of acute perioperative 
cardiovascular complications (CVC) and mortality. The patients with such specified 
pathologies need additional evaluation before major surgical intervention.   
The cardiac postoperative morbidity and mortality are closely related to the basic surgical 
disease and the corresponding intervention. Many scientific publications report on the high 
number of complications, accompanying the major surgical abdominal and intrathoracic 
interventions, emergency surgical interventions, surgery of malignant neoplasm, major 
peripheral vascular manipulations [1, 2, 3].      
The CR evaluation will not change the course and the result of the intervention in emergency 
conditions, e.g. rupture of abdominal aortic aneurism, heavy trauma, perforations etc., but 
may have influence upon the care during the early postoperative period. In emergency but 
noncritical states (e.g. biliary obstruction), the evaluation may contribute to risk reduction 
without influence upon the decision about the necessity of the intervention. In some cases, the 
CR evaluation may influence the surgical intervention planning and the choice of less invasive 
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intervention, e.g. the preference for peripheral arterial angioplasty before infrainguinal bypass, 
even though the long-term result of the surgery may be altered. In other cases, the CR 
assessment must support the decision for a given intervention, e.g. for removal of small 
aneurisms from asymptomatic patients with carotidal stenosis, when the compromise is 
between the expected life duration and the risk of the intervention.   
Below are presented some practices for cardiac risk assessment in emergency noncardiac 
surgery, including high risk one. Part of them are discussed on the basis of own studies over 
the applicability of models for CP evaluation in groups of subjects, differentiated upon the 
urgency, the severity of the surgical disease and intervention, with or without 
cardiovascular and other concomitant nonsurgical diseases [4, 5, 6, 7].      
2. Short review of preoperative cardiac risk assessment schemes in major 
noncardiac surgery 
2.1 General preoperative clinical assessment 
The tentative general assessment of the cardiac perioperative risk may be completed on the 
basis of factors with known contribution. 
2.1.1 Risk in patients with ischemic heart disease (IHD) 
The perioperative mortality reaches 9.6% in case of IHD, otherwise it is just about 2.8% [8, 
9]. Besides the hemodynamically induced complication, other manifestations like 
thrombosis, coronary spasm, serious rhythm disorder, spontaneous psychogenic nocturnal 
or preoperative complications, are also possible. The patients with IHD, subjected to major 
noncardiac surgery, can be divided into 3 groups:  
a. Patients with angina pectoris (АP).  
The preoperative assessment of patients with angina, who will be subjected to major noncardiac 
surgery (MNCS), has to clarify the following questions: stable or unstable angina; functional 
class (FC); is the medicamentous treatment adequate; necessity of specific diagnostic tests. 
Except for the surgery of abdominal aortic aneurism, the patients with I-II FC stable 
stenocardia have the resources to bear the stress of MNCS, while this intervention presents 
serious threats to patients with III-IV FC.  
The patients with I-II FC stable AP are with increased risk of cardiac complications after 
MNCS [10] (about 10 times higher relative risk compared to patients without IHD). 
However, this tenfold increase corresponds to a relatively low risk of myocardial infarction 
(MI), approximately of 4%, and of cardiac death, about 1-2% [8, 9]. FC is decisive in 
predicting the risk level of patients with stenocardia. Those of them that succeed to reach 
85% of the maximum cardiac frequency (even with appearance of ST-depression) have no 
complications during surgery [11, 12]. Just the opposite, the presence of ST-depression and the 
bad tolerance of physical stress identify the high-risk patients. 
b. Patients with MI 
The number of perioperative reinfarctions decreases with the improvement of the 
anesthesiologic methods from 30% to 6% after survived MI during the last 3 months, and 
from 15% to 2% after preceding MI during the preoperative 3-6 months.   
The MI manifestation during intra- or early postoperative periods is often preceded by 
prolonged or recidivistic ischemia. There are two important mechanisms in the context of 
the perioperative MI: 
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1. Chronic imbalance between the need and the providing of blood stream that is clinically 
manifested as stable IHD (due to coronary arteries’ stenosis, limiting the blood stream); 
2. Rupture of coronary plaque with clinical manifestation of acute coronary syndrome 
(ACS). 
c. Patients with high risk of asymptomatic IHD.  
Such are the patients with diabetes mellitus (DM) or peripheral vascular disease, when 
either the ECG stress-test cannot be carried out, or the results obtained are not reliable.   
2.1.2 Risk in patients with heart failure (HF) 
The congestive heart failure (CHF) increases the risk of postoperative complications. Here, it 
is important to clarify as far as possible, the HF etiology. For example, HF due to 
hypertension runs a different risk, compared to HF due to IHD [13, 14]. 
Many general anesthetics cause direct myocardial depression. Very often, a large quantity of 
liquids is infused during the perioperative period in MNCS and overburden the patients 
with left ventricular dysfunction or HF. The risk of perioperative cardiogenic pulmonary 
edema among subjects aged over 40 years, who have been subjected to MNCS, vary from 
about 2%, if CHF anamnesis is absent, through about 6% for patients with preceding HF, 
which is not present during physical and X-ray examinations, and reaches up to 16% with 
persisting physical and X-ray data about pulmonary stagnation [8].   
Large abdominal or thoracic surgery, which is followed by CHF that has not been identified 
before the intervention, is usually associated with elderly patients with ECG abnormalities 
or other cardiac symptoms [15]. 
The presence of CHF represents another risk factor for perioperative MI [16, 17, 18, 19]. 
2.1.3 Risk in patients with heart valvular disease 
The patients with heart valvular disease, who have been subjected to MNCS, are subject to 
an increased risk of cardiac complications, mostly because of their susceptibility for 
development of CHF, hypo- and hypervolemia and cardiac arrhythmias in the perioperative 
period [13]. About 20% of the patients with severe heart disease (II or higher FC) either 
evolve new or complicate the present cardiac decompensation during the MNCS [15]. It is 
accepted, that the subjects with aortic stenosis are the higher risk patients among these with 
valvular cardiac disease, as they bear with difficulty hypo- and hypervolemia [20]. 
The patients with combined rheumatic mitral and aortic heart disease represent a 
considerable group. Their risk during noncardiac intervention is high, because of their 
limited resources and capabilities to support changes in pre- and afterloads.   
2.1.4 Risk in patients with cardiac arrhythmias 
The arrhythmias, either atrial or ventricular, are often related to IHD or CHF and specify 
increased risk during MNCS. Although both arrhythmias are pointed out as independent risk 
factors in the perioperative period [20, 21, 22], they probably have significance only as a 
manifestation of serious heart disease, which itself increases the risk of CVC. In similar cases, 
the arrhythmias correlate as a marker of cardiac suffering with ischemic and HF complications 
and do not contribute additional risk during noncardiac surgery. According to Detsky et al and 
Goldman et al, the prognosis in patients with arrhythmias, but without supporting cardiac 
pathology, is usually good and the risk of intervention is very unlikely to be increased, although 
the same authors determine the atrial fibrillation as an independent risk factor [20, 23]. 
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High risk of the supraventricular tachiarrhythmias progress subsists among elderly patients 
subjected to pulmonary surgery, patients with subcrucial valvular stenosis and patients 
with primary anamnesis of similar tachyarrhythmias [24]. 
Patients with anomalies in the conductive system as AV block, fascicular or bundle branch 
block often have cardiac diseases. Many anesthetics suppress the cardiac contractility 
and/or provoke peripheral vasodilatation. The anesthesia may give rise to further 
depression of the automatism and, consequently, of the ventricular frequency in patients 
with heart block. The complication of biphascicular block after MI may progress to a third 
degree AV block, often accompanied by serious hemodynamic disorders [24, 25].    
Patients with bundle branch blocks are not subject to increased risk of third degree AV block 
progress in the perioperative period, although they may acquire it in a long-term context. 
The presence of bundle branch block does not represent an independent predictor of heavy 
postoperative cardiac complications if there is no evidence of other severe disease [15, 20]. 
According to the recommendations of the ACC/AHA the arrhythmias with high risk are as 
followed [2]: 
- high-degree AV block; 
- symptomatic ventricular arrhythmias, combined with presence of cardiovascular 
diseases (CVD); 
- supraventricular arrhythmias at high and out-off-control heart rate (HR). 
2.1.5 Arterial hypertension 
Despite contemporary achievements in arterial hypertension (AH) diagnosis and 
monitoring, a large percent of the subjects with AH remain without diagnosis or have been 
inadequately treated. The patient arterial blood pressure (BP) may increase in a hospital 
environment as a result of a stress. Prys Roberts et al, report higher perioperative BP 
instability among subjects with high preoperative BP [26]. According to Goldman and 
Caldera [8], the mean intraoperative BP, the necessity of infusion and adrenergic agents for 
supporting the pressure during the intervention, as well as the progress of considerable 
postoperative hypertension, practically are not influenced by the fact whether the 
hypertension was not treated, inadequately treated or well monitored.    
Several communications [15, 20, 23, 27] point out that patients with mild through moderate 
hypertension can be subjected to anesthesia and intervention without high risk of CVC [8]. 
Other studies cite as evidence that patients with AH are subjected to higher risks of cardiac 
complications during, or immediately after, MNCS, compared to normotensive subjects. The 
reasons of the increased risk are due to IHD, left ventricular dysfunction, renal failure, or 
other disorders commonly encountered among patients with AH [26]. The subjects with AH 
have increased IHD and CHF risk and tendency towards most frequent manifestations of 
silent myocardial ischemia during surgery [28].    
2.1.6 Cardiomyopathies 
The hypertrophic cardiomyopathy raises some specific problems. The reduction of the blood 
volume, the decreased vascular system resistance and the increased venous volume can 
reduce the left ventricular volume and increase the tendency towards obstruction of the left 
ventricular output tract. In addition, the decreased pressure of the ventricular filling may 
lead to considerable reduction of stroke volume, due to reduced compliance of the 
hypertrophic ventricle. 
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2.1.7 Peripheral vascular diseases 
They add certain perioperative risks, since they are often associated with accelerated 
atherosclerosis and IHD [2]. 
2.1.8 Other risk factors 
2.1.8.1 Age 
Advanced age is an independent risk factor for perioperative complications [2, 17, 18, 25], 
not only because of the increased probability of coronary disease, but also because of the 
senescent effect on the myocardium – decrease of the myocytes number. The mortality 
caused by acute MI considerably increases with the age. The perioperative MI have higher 
mortality among the elderly patients [29].  
2.1.8.2 Sex 
The women have lower cardiac risk except for present early climax or DM [2]. They have 
lower frequency of IHD, and coronary disease is observed 10 years later, compared to men. 
In the case of early climax and DM, the risk is equal to that of men at the same age. 
Mortality, due to acute MI, is greater among women than men, and this difference is even 
more evident with advancement of age and presence of DM.   
2.1.8.3 Diabetes mellitus 
DM increases the probability of IHD appearance, but the myocardial ischemia is often silent. 
DM frequently is considered as a risk factor for cardiac complications in the MNCS 
perioperative period [17, 30, 31].  
2.1.8.4 The chronic pulmopathies  
The chronic pulmopathies present a high perioperative risk [32], which is dependent on the 
severity of the pulmonary disease and the intervention duration. 
2.1.9 Type of surgical intervention 
The surgical risk represents a complex assessment, which includes the severity of the basic 
surgical disease, the treatment method and the patient condition. In addition to the present 
data about cardiovascular pathology that influences the prognosis, other basic surgical 
factors can provoke exacerbation of present chronic cardiac diseases or appearance of 
perioperative CVC. Their number is twice higher with infectious inflammation (sepsis) or 
neoplastic disease [33].  
The basic surgical disease is a leading factor for localization, size and duration of the 
intervention, as well as for the conditions necessary for its performance [34]. The surgery of the 
thoracic and abdominal aorta contributes the highest risk among the noncardiac interventions, 
because of the accompanying problems with the water balance, bleeding and oxygenation. The 
abdominal interventions take the second place in frequency of concomitant CVC, following 
the thoracic ones [35]. The interventions of carotidal and peripheral vessels are also associated 
with increased risk of cardiac complications. It is known, that up to 50% of patients 
undergoing interventions of the peripheral arteries suffer MI in the next 2-3 years [36].      
2.1.9.1 Surgical factors  
Surgical factors, which influence the cardiac risk, are associated with the emergency, the 
complication, the type and the duration of the intervention, as well as with the change of 
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the body temperature, the loss of blood and the body liquids exchange. The intervention 
emergency represents an issue of special importance. The survival rate increases twofold 
with preoperative intensive cardiac care that is related to eventual delayed emergency 
intervention, whenever that is possible [37]. Each surgery provokes a stress reaction, due 
to tissue damages and is mediated by neuroendocrine factors that may lead to 
tachycardia and hypertension. The perioperative stress reaction includes effusion of 
catecholamine, provoked by the hemodynamic stress, vasospasm, reduced fibrinolitic 
activity, activated trombocytes and extracoagulation. Coronary plaque rupture leads to 
thromboses and subsequent vessel occlusion, which are important factors for the 
occurrence perioperative ACS. The MI among patients with significant IHD may be a 
result of a continuous imbalance between the available and the necessary myocardial 
blood steam (in cases of tachycardia and increased myocardial contractility). Studies on 
performed autopsies, demonstrate that half of the fatal MI have directly destroyed 
plaque fissure, rupture or plaque bleeding. Although the specific patient factors are more 
important for cardiac risk prediction than the surgical ones, the type of the surgical 
intervention cannot be ignored.     
2.1.9.2 Type of the anesthesia 
Recent studies indicate, that the operative period is more reliable than it was in the past, 
mostly because of the careful monitoring of hemodynamics and respiration during the 
anesthesia [20]. No data are available for determining some significant differences in the 
severity of the cardiac complications due to the different anesthesia techniques. However, 
the assessment of the type and the conditions of the anesthesia may have important 
implications for the cardiac risk prognosis. 
2.2 Indices and scales for cardiac risk evaluation and their applicability on cardiac 
risk assessment in patients with emergency high risky noncardiac surgery 
The preoperative assessment of cardiac risk during noncardiac surgery (specifically for 
emergency surgery) is based on quantitative indices and rated scales. They were proposed 
and introduced initially for assessment of the anesthesiology risk and consequently, for the 
cardiac one [20, 23, 38, 39].   
The synthesis of methods for preoperative cardiac risk assessment began intensively at the 
end of the seventies, as a result of the communication by Goldman et al [17, 19, 20, 23, 40, 41, 
42, 43, 44, 45, 46]. The methods and indices for the cardiac risk assessment can be 
characterized as: 
- common for CR [20, 25, 27, 42]; 
- specifically related to the risk of ischemic complications – underestimated by Goldman 
et al, although it is the most dynamic and dangerous risk factor (RF) [17,19, 40, 41, 43, 
44, 45, 46]. 
From another point of view, the methods and indices for cardiac risk assessment are:  
- quantitative [20, 23, 27]; 
- qualitative [17, 19, 40, 41, 42, 43, 44, 45, 46, 47]. 
2.2.1 Quantitative (point) indices 
The CR index in noncardiac surgeries that was introduced by Goldman et al [20] represents 
a point assessment and is still largely applied in practice. This index is derived over data of 
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patients with MNCS, such as aortic, pleural, intraoperational and intrathoracic 
interventions. It includes 9 preoperative assessable indices with own quantitative 
contribution to the amount, which determines the perioperative CVC risk. The risk is 
distributed in 4 classes: I-st class (0 to 5 points) with live-threatening complications and 
cardiac death of 0.9%;  II-nd class (6 to 12 points) with 7% rate of such complications; III-rd 
class (13 to 25 points) with 14% rate; IV-th class (26 and over points) with expected rate of 
live-threatening complications and cardiac death of 77%. The indicator “Poor general 
condition” includes the criteria: PO2 < 60; PCO2 > 50; K < 3; HCO3 < 20; BUN > 50; Creat > 
3; elevated SGOT; chronic liver disease; bedridden. 
Detsky et al [23] modified Goldman’s index on the basis of clinical evaluation and 
monitoring of non-selected patients over 40 years old with MNCS. Within that index, the 
timing of the previous MI is divided into less or more than 6 mounts ago, while the 
influence of the stenocardia is specified according the adopted division as stable (with 
differentiated classes) and unstable; the anamnesis of the pulmonary edema is also included. 
It is accepted, that Goldman’s index is equally informative as the extended index of Detsky 
et al [23], but the first does not include III and IV class stenocardia, while Detsky et al 
introduced such corrections. The atrial fibrillation is included as RF too. Subsequent studies 
establish its significance, whenever this cardiac disorder is currently manifested [53]. AH 
was also evaluated at a later stage, but from the heart defects, only aortic stenosis is 
included.  
The pivotal points of Goldman’s index are the presence of MI and HF. The index of Larsen et 
al [27] includes metabolic deviations in parallel with CVD. Here the volume, the nature and, 
especially, the surgical conditions (emergency or planned) are assessed in greater detail. On 
the basis of that, Larsen et al managed to integrate the CR index with the type of surgical 
intervention. The index of Larsen et al can reach a maximum value of 54 points – divided by 
the level and actuality of HF and IHD, as well as other conditions.   
In 1999, Lee et al [48] reevaluated the significance of some clinic risk factors, associated with 
patients undergoing noncardiac surgery. The revised index sets 6 predictors of major 
cardiac complications: high risk surgery, IHD, HF, cerebrovascular disease, type 1 DM and 
renal insufficiency. The presence of 0, 1, 2 or 3 of the predictors sets the risk level of major 
cardiac complications at 0.4%, 0.9%, 7% and 11%, respectively. The index of Lee et al has 
better prognostic value than those of Goldman et al and Detsky et al, due to the smaller 
number of variable risk factors. For the time being, the clinicians and the researchers accept 
Lee’s index as the most applicable for prediction of the perioperative cardiac risk in 
noncardiac surgery. However, the patients examined by Lee et al do not constitute a 
representative population of patients undergoing noncardiac surgeries, since the thoracic, 
the vessel and the orthopedic cases are over-represented.      
2.2.2 Non-point scales for cardiac risk assessment 
The scale of Kleinman [42] includes remoteness of MI, angina pectoris, valvular disease, 
rhythm disorders, arterial hypertension, abnormal ECG, peripheral vascular diseases.  
The scale of Eagle et al [47] includes age over 70 years, DM, angina pectoris, presence of 
pathological Q-wave in ECG and ventricular extrasystoles.  The presence of one RF 
determines low risk, the presence of 2 to 3 – moderate risk, while more than 3 risk factors 
leads to high risk assessment. 
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Later on, diagrams and tables for risk assessment of ischemic complications [19, 41, 43], life-
threatening ischemic complications [17, 36, 44, 45], tachyarrhythmias [24], and 
ventricular arrhythmias [49] were proposed. The scales and the statements about the 
probability of ischemic complications comprise of several symptoms, derived from 
clinical, laboratory, imaging, and electrophysiological examinations. Hopf and Tarnow 
[41] propose intraoperative ECG monitoring, transesophageal echocardiography, which 
is a semi-invasive and expensive method, cardio-kymography, radio-marked 
erythrocytes and small gamma camera, as well as metabolic parameters. Lette et al [43] 
reach the conclusion that the clinical parameters can not predict incoming ischemic 
incidents. They accentuate on dipyridamole-thallium scintigraphy. Leppo [19] includes 
ECG examinations, treadmill, stress-echocardiography with dobutamine or exercise, 
thallium scintigraphy with test burden in the preoperative assessment. Symptomatic 
angina, CHF, survived MI, ventricular extrasystoles, and age over 70 years, are also 
taken into consideration. 
Mangano et al [50] evaluate the significance of the following clinic symptoms, related to the 
appearance of post-operative ischemic complications: 1) presence of left ventricular 
hypertrophy in ECG; 2) remoteness of the arterial hypertension; 3) diabetes mellitus; 4) 
manifested IHD; 5) HF needing the use of digoxine. According to the presence of the five 
preoperative symptoms for postoperative ischemia, the probability of its perioperative 
appearance is divided into 5 levels: without any symptom presence – 22%; presence of one 
symptom – 31%; 46% with two symptoms; 70% with three; 77% with four symptoms.   
Other studies of the same authors emphasize the significance of the following conditions, 
contributing to unfavorable outcomes from ischemic complications [44, 45]: 
1. intraoperative hypotension and tachycardia (the assessment of hypertension is 
contradictory); 
2. appearance of acute ischemic events in the postoperative period (acute MI), unstable 
stenocarida or ECG ischemia. Note that CHF and ventricular tachycardia are not 
associated with unfavorable outcomes; 
3. instrumentally determined intra- and postoperative changes: appearance of ECG 
ischemia (doubles the MI risk); increases of the endmost left camera diastolic pressure 
that are accepted as evidence of ischemia - note that the mean pulmo-capillary pressure 
and the diastolic pulmonary arterial pressure do not correlate with the incidents; 
segmental disorder of the left camera wall assessed by transesophageal 
echocardiography  - that is accepted as the most sensitive predictor [51], although the 
same authors specify later on, that transesophageal echocardiography weakly correlates 
with postoperative complications; 
4. the presence of AH, heavy limiting lung disease, creatinine clearance lower than 0.8 
ml/s – factors independently associated with high risk of cardiac death [45]. The death 
probability is 80% when two or more factors are present.    
If the total rate of complications with all monitored patients is 12%, then 24% of those with 
old MI or cardiomegaly have postoperative complications – cardiac death, acute MI, 
ischemia. The rate of patients without the mentioned consequences is only 7% [52]. 
A standard for CR assessment during noncardiac surgeries [22, 53, 54] was adopted, on the 
basis of the debates, concerning the applicability of the schemes and indices for CR 
assessment and the ACC/AHA proposals [22, 53, 54]. According to it, CR is further divided 
into three groups – high, moderate, and low, depending on the severity of the perioperative 
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CVC and the probability of a fatal outcome; the significance of the clinical predictors is 
determined, as well as the volume and type of the surgery.  
1. Risk, related to CVD: 
a. high: 
the unstable coronary syndromes – new MI and unstable stenocardia; 
the decompensated HF; 
the significant arrhythmias – high-degree  AV block, symptomatic ventricular 
arrhythmias accompanying cardiac disease, as well as supraventricular arrhythmias 
with uncontrolled HR; 
critical valvular cardiac lesion.  
b. moderate: 
stable stenocardia – I-II FC; 
old MI or present pathological Q wave in ECG ; 
compensated HF;  
diabetes mellitus. 
c. lower: 
advanced in years; 
ECG abnormalities; 
non-sinus rhythm; 
bad functional capacity; 
past apoplexy; 
uncontrolled arterial hypertension. 
2. Risk, related to surgical intervention: 
a. high:  
emergency major interventions, specifically with elderly patients; 
aortic and other major vessel interventions;  
peripherally vessel surgeries;  
extended surgeries, accompanied by loss of many liquids and blood .  
b. moderate: 
carotid endarteriectomy; 
cranial and vertebral surgeries; 
intraperitoneal and intrathoracic surgeries; 
orthopedic surgeries; 
prostate surgery. 
c. lower: 
endoscope procedures; 
procedures on the body surface; 
cataract and  breast surgeries. 
The ACC/AHA classification merits consist of classification of the risk categories, as well as 
the consideration of the cardiac state and type of surgery. Are specified the rhythm 
disorders, the low risk predictors and the pathological ECG findings. 
There are several investigations and analyses on the applicability of the CR indices 
evaluation [1, 11], including such on large number of patients [23]. Basic disadvantages of 
indices are the high percent of false-positive conclusions [38] and the impossibility of 
obtaining accurate diagnosis and assessment of the most serious and dynamic RF – the 
ischemia, with pain or silent [9, 31, 45, 56]. The CR indices do not determine the appearance 
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probability of acute ischemic incidents [9, 31, 57] and that is what significantly affects the 
reliability of the cardiac death prognosis. 
The point indices of Goldman et al and Larsen et al include the emergency and the operation 
volume in the criteria set for the index calculation, but with the lowest possible weights: 4 
and 3 with Goldman et al (in the assessment range from 3 through 11) and 3 and 3 with 
Larsen et al (in the range from 3 through 12). The detailed analysis of the two schemes gives 
a satisfactory answer to both the low discrimination coefficients (used for calculation of the 
emergency and severity of the surgery with both models), and their unavoidable presence 
among the criteria. Table 1.1 details systematically the required data. 
 
Data for investigation of : Goldman et al Larsen et al 
 
Total number of surgeries (TNS) 
 
1001 
 
2609 
Total number of heavy cardiac complications including 
cardiac death (HCC) 
 
58 
 
68 
 
Emergency surgeries (ES) 
 
197 
 
605 
Heavy cardiac complications (including cardiac death) 
in emergency surgeries (HCCES) 
 
31 
 
38 
Emergency surgeries /Total number of surgeries 
(ES/TNS) 
19.7% 23.2% 
Heavy cardiac complications in ES/Total  number of 
heavy cardiac complications (HCCES/HCC)  
 
Exceeding index (EIES) 
 
35.4% 
 
271% 
 
56% 
 
241% 
   
 
Major surgeries * (MNCS) 
 
437 
 
857 
Heavy cardiac complications (including cardiac death) 
in major noncardiac surgeries (HCCMS) 
 
43 
 
40 
Major surgeries/Total number of surgeries (MS/TNS) 43.7% 32.8% 
Heavy cardiac complications in major surgeries/ Total 
number of heavy cardiac complications (HCCMS/HCC) 
 
Exceeding index (EIMS) 
 
74.1% 
 
170% 
 
58.8% 
 
179% 
   
* Major surgeries: aortic, pleural, intraperitoneal, intrathoracic. 
Table 1.1. Exceeding indices  for emergency and major noncardiac surgery 
The proportion between the cardiac complication rates, accompanying the emergency and 
major surgeries on the one hand, and the total cardiac complication rates for all patients on 
the other, considerably exceeds the corresponding proportion between the emergency and 
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major intervention rates to the total number of interventions. We devoted special attention 
to that fact, in our targeted study [5, 6] introducing the so called “Exceeding Indices.” The 
Exceeding Index, applied to the emergency surgeries (EIES) expresses the quotient (in 
percent) between the relative rate of the heavy cardiac complications (including cardiac 
death) accompanying the emergency surgeries (HCCES), towards the total number of heavy 
cardiac complications (HCC), and the relative rate of the emergency surgeries (ES) towards 
the total number of surgeries (TNS): 
EIES (%) = (HCCES/HCC)/(ES/TNS). 
Respectively, the Exceeding Index of the major surgeries (EIMS) expresses the quotient (in 
percent) between the relative rate of the heavy cardiac complications (including cardiac 
death) accompanying the major surgeries (HCCMS) towards the total number of heavy 
cardiac complications (HCC), and the relative rate of the major surgeries (MS) towards the 
total number of surgeries (TNS): 
EIMS (%) = (HCCMS/HCC)/(MS/TNS). 
The emergency surgeries, representing about 1/5 of a relatively small group used with both 
studies [5, 6], demonstrated a specific rate of cardiac complications that is 2.5-3 times higher 
than the one, observed for the entire group. The same parameter for MNCS indicates an 
increase of 1.5-2 times.  
It is worth noting that the “Exceeding Indices” makes evident the practically total 
coincidence between the results obtained by Goldman et al and Larsen et al about the 
“weights” of the emergency and the intervention volume, despite some differences within 
the constellations of the other criteria used by both point systems. The reason for the 
mentioned emergency and major surgery “classification”, completed by both systems 
becomes clear – on the one hand, they do not predominate over the total number of 
interventions, i.e. they do not determine the nature of the used samples; on the other hand, 
they bring considerable CVC risk in the perioperative period that can not be ignored by the 
used statistical analysis.  
The analysis of the results obtained, when applying both indices of CR assessment towards 
the three specific patient groups, generally indicates a significant discrepancy between the 
formally calculated assessments and the concretely recorded cardiac complications in the 
perioperative period. There are certain possible hypotheses, offering reasons for the limited 
applicability of the index models for CR evaluation under the emergency MNCS conditions: 
1. The criteria with considerable contribution to the total risk assessment (point 
assessment above the mean for a given criterion of the corresponding model) have a 
relatively low rate and/or are weakly informative in emergency surgeries, while the 
criteria with lower contribution (point assessment below the mean for a given criterion) 
have a relatively high rate or are highly informative in emergency surgeries. 
2. More important contribution to the cardiac risk evaluation in cases of emergency 
MNCS have other criteria, which are not included in both models. 
In our opinion, both hypotheses are realistically supported by the analysis performed. We 
reiterate, that the emergency and the surgery severity (markedly demonstrated with the first 
group of patients) dominate as cardiac risk predictors. However, these criteria are not direct 
detectors of the heart status; they specify the surgical heart burdening, which is the reason for their 
predominance in patients with cardiac diseases. The constellation parameters of both models are 
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deficient in direct criteria for cardiac status evaluation; this fact is relevant to a greater extent 
for Goldman’s model.  
The relative advantages of Larsen’s model may be well explained by the adequately 
introduced cardiac status criteria. The IHD assessment criterion includes: 1) MI presence 
during the 3 last months (Goldberger et al specify 6 months); 2) older infarction or angina 
pectoris (missing in Goldberger’s model). The data analysis shows that the second index, 
even appreciated by 3 points only, is significantly more frequent, about 15% of the cases 
with critical patient complications. At the same time, MI presence during the last 3 or 6 
months (indices with high value, 10 and 11 in both models, respectively) is recorded with 
one patient, who did not demonstrate perioperative complications. Our interpretation is that 
the recent (and generally severe) cardiovascular incidents have no explicit contribution to 
the risk evaluation, since they are subject to therapeutic monitoring. This is not the case with 
patients with chronic and mild incidents and generally more distant in time CVD and their 
complications. In emergency cases, the possibilities for correction are missing, that are 
inherent to planed surgery, even when the complications are under- or decompensated.  
Considerable contribution to the cardiac risk assessment in the model of Larsen et al, have 
indices characterizing in aggregate the “heart failure” criterion. Within the investigated by 
us patient group, with present or preceding pulmonary stagnation, heart failure is a 
considerably more frequent postoperative CVC. The conclusion is highly valid among 
patients with stagnations, confirmed by X-ray examination. In such cases, the corresponding 
cardiac risk assessment increases by 12 points (at persistent pulmonary stagnation) or by 8 
points (without stagnation but with preceding pulmonary edema).   
Important for the correct cardiac risk evaluation are the cases, offering indices for combined 
criteria, that are assessed by low point amounts from 2 to 4, such as preceding HF without 
stagnation or edema; preceding IHD with or without old MI; diabetes; increased serum 
creatinine. The combination of three of the mentioned indications, accompanying the 
emergency abdominal surgeries (very common case in practice), leads to a risk increase in 
the range of 12 through 50%.   
Special comment is needed on diabetes, included as a indicator in Larsen’s model. In addition 
to the specific complication, diabetes is associated with the IHD. Introduction of diabetes in 
cardiac risk evaluation is appropriate, bearing in mind its frequency. It was encountered in 
22.4% of the patients, examined by us. The percent of the heavy CVC in patients with diabetes 
is 14.5. In comparison, it is 8 with patients with mild CVC complications.    
The discussion on the applicability of the index models does not cover the problems related 
to the adequate evaluation of the used criteria constellations for CR assessment in 
emergency noncardiac surgery. Evidently, there are other criteria, which reliably predict 
(directly or indirectly) the probability of cardiovascular incidents during the perioperative 
period. 
3. Real and relative myocardial ischemia as a risk factor for appearance of 
acute cardiac complications in emergency noncardiac surgery – Index for 
cardiac risk assessment, through ST-depression in the preoperative ECG 
Most well known studies indicate the manifested myocardial ischemia as a proven predictor 
of perioperative cardiac incidents. Different investigations report preoperative ischemia 
found in 28% through 32% [50, 58] of the examined cases; other refer to a value of up to 60% 
[59]. The preoperative ischemia, established by Holter monitors, is a predictor of the 
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perioperative one [60]. When the preoperative ischemia is determined by two-days of ECG 
monitoring, the perioperative complications are specified as 18%, 21% of them being cardiac 
death, AMI, and unstable stenocardia; 35% are HF; 44% - ventricular tachycardia [9]. The 
influence of the real and relative myocardial ischemia on perioperative CVC appearance is 
evident. Therefore, it is useful to associate the CR evaluation with the ECG determined ST-
depression. The introduction of an index for CR assessment provides an understandable 
and objective method for CVC risk determination in cases of preoperative ECG manifested 
myocardial ischemia (MMI) during emergency noncardiac surgeries. This paragraph 
presents a synthesis of the cardiac risk assessment index (CRI) for CVC prediction in the 
postoperative period, based on ST-depression in preoperative ECG, as an expression of 
real/relative myocardial ischemia. 
Data obtained by monitoring the disease process within a group of 466 patients is used for 
CRI synthesis. The patients have been emergency treated against acute abdominal surgical 
diseases or abdominal traumas. The patient distribution within the investigated surgical 
nosological groups (ING) is presented in increasing order of surgical disease (SD) severity in 
Table 2.1.  
The CRI synthesis is related to assessment and comparison of the CVC rate of patients with 
and without MMI in the ING. CVC appeared in 169 (36.3%) of ING patients: 51 (64.5%) of 
them with MMI and the remaining 118 (30.9%) – without MMI. The statistically significant 
difference (р<0.001) shows that MMI is an important RF. This general evaluation of the MMI 
influence on the patients in the postoperative period has to be specified for ING in 
increasing order of their severity. Table 2.2 presents the CVC rate (in percent) found in ING 
patients with and without MMI.  
The frequency of CVC in patients without MMI marks the anticipated increasing trend in 
accordance with the increased SD severity – from the low 5.5% among patients with acute 
appendicitis, through the significant 33, 34, and 35% for patients with hernia, abdominal and 
biliary-pancreatic diseases, to the high 54% related to acute states, provoked by pathologies 
of the lower part of the gastrointestinal tract.  
The CVC rates in patients with MMI are obviously higher, but as a trend, they do not repeat the 
monotonic CVC rate increase with SD deterioration of patients without MMI. A characteristic 
peak may be observed in group B (77%); high rate in group E (71%); limited increase in С (62%) 
and D (65%) groups. Group A remains with the most rare CVC cases (40%). 
The statistically significant difference between the CVC rates in ING, among patients with 
and without MMI, underlines the specificity of the two trends. Significant, even at different 
levels, are the differences in groups A, B, C and D. The high level (р<0.005) in group B 
corresponds to the highest recorded increase of the CVC rate, when comparing the results of 
patients with and without MMI (from 33% to 77%). The differences in groups A and D 
(р<0.005) are also derived with high significance, due to the considerable CVC percentage 
among the MMI patients. At the same time, the difference in group E between the CVC rate 
among patients with and without MMI is not significant. 
The analysis of the trends in the CVC rates demonstrates the necessity of a detailed 
discussion on the MMI influence as an ING risk factor. 
The CVC are separated as lethal and nonlethal, depending on the recorded disease outcome. 
Nonlethal CVC appeared in 136 (29.2%) patients of the investigated group: 38 (48.1%) of 
them with and 98 (25.3%) without MMI. Lethal CVC were observed in 33 (7.1%) patients, 13 
(16.5%) with and 20 (5.2%) without MMI. 
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Surgical disease Code Number 
Acute appendicitis A 102 
acute phlegmonous appendicitis   
acute gangrenous  and perforated appendicitis   
Complicated hernia B 92 
Incarceration inguinal and ventral hernia without 
complications 
  
Incarceration inguinal and ventral hernia with intestinal 
necrosis or  intestinal phlegmon 
  
Gastro-duodenal C 84 
Gastro-duodenal ulcer with perforation   
Gastro-duodenal ulcer with hemorrhage   
Gastro-duodenal ulcer with stenosis   
Gastric neoplasia with perforation or hemorrhage   
Hepatopancreatobiliary D 108 
Acute or chronic exacerbated cholecystitis   
Complicated cysts, tumors and abscess of liver   
Mechanical icterus   
Acute pancreatitis-with edema, necrotic pancreatitis or 
absceding  necrotizing pancreatitis 
  
Intestinal E 80 
Benignant ileus   
Malignant ileus   
Spontaneous intestinal perforation (including intestinal 
diverticulum, ulcerative or necrotic colitis) 
  
Colo-rectal neoplasia with perforation or hemorrhage   
Mesenteric thrombosis   
Inflammatory and neoplastic tumors of abdominal wall   
Table 2.1. The patient distribution of the surgical nosological groups in increasing order of 
severity. 
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Group of 
surgical 
diseases 
Total number 
of CVC to the 
number of 
patients (in %) 
in the group 
accordingly 
Number of 
lethal CVC to 
the total 
number of 
CVC (in %) in 
patients 
Number of 
nonlethal 
CVC to the 
total number 
of CVC (in %) 
in patients 
Number of 
lethal CVC to 
the number of 
patients (in %) 
in the group 
accordingly 
Number of 
lethal to the 
number of 
non-lethal 
CVC (in %) in 
patients 
Mean age of 
the patients in 
the surgical 
groups 
       
 
With-
out 
MMI
With 
MMI
With-
out 
MMI
With 
MMI
With-
out 
MMI
With 
MMI
With-
out 
MMI
With 
MMI
With-
out 
MMI
With 
MMI
With-
out 
MMI 
With 
MMI 
A 5,5 40 0 0 5,5 40 0 0 0 0 37 58 
B 33 77 4 10 32 69 1 8 3 12 69 75 
C 34 62 8 25 31 46 3 15 10 33 61 68 
D 35 73 21 24 28 50 7 23 25 46 55 63 
E 54 71 32 50 37 35 17 35 50 100 62 72 
Table 2.2. CVC and age profiles in surgical groups 
Lethal CVC were not recorded among patients in group A, either with or without MMI. 
These complications among patients without MMI increase gradually, even weakly in 
groups B (1%), C (3%) and D (7%), but considerably in group E (17%). The trend of the 
lethal CVC rates among MMI patients is also increased, but highly expressed in the range 
of severity groups:  8%, 15%, 23% and 35% in B, C, D and E, respectively. Except for group 
A, there are significantly higher CVC rates among MMI patients, compared to these 
without MMI (р<0.05). The nonlethal CVC rate in patients without MMI increases from 
5.5% in group A to approximately equal levels in groups B (32%), C (31%) and D (28%), 
but more expressively in group E (37%). This rate reaches the peak among MMI patients 
in group B (69%), compared to the almost equal and lower rates in A (40%), С (46%) and 
D (50%). The low rate (35%) of nonlethal CVC patients with MMI in group E is 
impressive, and practically equal to the rate of patients without MMI. This is true also for 
the many times higher CVC rate in group A among MMI patients, comparing to patients 
without MMI (p<0.001). These data determine the high significance of the rate differences 
in group A and the lack of such difference in group E. Nonlethal CVC were observed in 
groups B and D as statistically significant  more often with MMI patients than among 
those without MMI, although the calculated significant level is lower (p<0.05). The 
difference in group C is not significant.    
The consequence of the differentiated analysis on the CVC rates with and without lethal 
outcomes is that the above mentioned specificity of the rate trends of all CVC in patients 
with MMI is totally determined by the rate trend of the low (nonlethal) complications. The 
lethal complications rate in the MMI group follows the increasing trend from group A with 
the low surgical severity to group E with the considerable severity of SD, but this trend is to 
some extent higher in patients without MMI. Among the nonlethal CVC, the most 
significant differences are in the groups A and B with low severity SD, while group A shows 
the highest relative increase in complications (7.3 times). The increased value of 2.2 times in 
group B is obtained with highest absolute percent of 69% of nonlethal complications among 
MMI patients. 
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The differentiated MMI evaluation as a risk factor, reveals its different contribution to the 
critical complications structure (lethal and nonlethal) of ING patients with and without 
MMI. Both ratios equal zero due to lack of lethal CVC in group A. In this group, with low 
severity SD, MMI is a risk factor only in cases of mild complications.  
In group B, despite the lesser level of significant difference (р<0.1), MMI stands out as a 
factor emphasizing the CVC and their prognoses. In groups with increased severity SD (C 
and D) this difference is p<0.05,which is convincing proof of the MMI importance for the 
CVC structuring. The significance of the MMI contribution has its logical maximum 
(р<0.001) with the CVC appearances and outcomes in group E, the group with considerable 
surgical severity.    
The results obtained, outlining the role of MMI as a risk factor of increased severity of CVC 
rate in SD with increased severity, need specification of the factor, which underlines the 
specifics of the nonlethal CVC rate trend among MMI patients, reflected also in the structure 
of the total number of CVC.  
The role of age as risk factor in CVC appearance and their complicated duration is known. 
We will limit our scope to clarification of its specific contribution to the CVC structure in the 
ING, thus evaluating the CVC risk among patients with and without MMI. The highest 
mean age of such patients is recoded with the lowest level of significance in group B - 69 
and 75 years, respectively, with the lowest level of significance of  p<0,05. This expressed 
high and near mean age in both types of patients in group B, may be well interpreted by the 
SD nature – the complicated abdominal hernias. The age discrimination among patients 
with and without MMI (37 and 58 years) is most expressed in group A, where the 
significance level of difference is high: p<0.005. Practically the patients of this group are 
clustered in two sets – young without MMI and elderly with MMI. Such clusters have 
considerably nearer values in groups C, D and E (61 and 68 years, 55 and 63 years, 62 and 72 
years, respectively) that determines the lower significance levels of difference. The mean age 
of MMI patients in the very serious SD (group E) is relatively high (72 years) and come close 
to that in group B.        
The low surgical severity group A of MMI patients often contains nonlethal CVC; it is 
characterized by a relatively high mean age. Such age, combined with MMI, determines the 
frequency peak of the nonlethal CVC in group B, which also consists of relatively low 
surgical severity SD. The lethal CVC are more frequent in group E, because of the 
considerable surgical severity SD and the high mean age of the MMI group; the nonlethal 
CVC rates among patients with and without MMI are equaled. In comparison to MMI, the 
age has prevalent importance towards the appearance of nonlethal CVC, in the cases 
discussed above. 
The performed analysis and the results obtained allow quantitative assessment of the 
increasing risk of CVC in patients with MMI in ING, taking into consideration the age 
profile, expressed by indices synthesis: general – for prognosis of all CVC, and specific – for 
the lethal CVC prognosis only. Based on the related to the SD groups content of Table 2.2:   
1. relation between rates of all CVC in patients with and without MMI  
(FAC+MMI/FAC-MMI)SD; 
2. mean ages of patients with and without MMI 
 (MA+MMI/MA-MMI)SD, 
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we can constitute a relation between the rates of all CVC in patients with and without MMI, 
adjusted to the corresponding mean ages: 
TCRISD = (FAC+MMI/FAC-MMI)SD/(MA+MMI/MA-MMI)SD 
The last equation is the total, age-corrected CRI, which gives assessment of the MMI  “net 
contribution” to the increased risk of CVC appearance individually in each SD group, and is 
relevant for a “conditional” patient whose age is equal to the mean age within the group. 
The MMI assessment of a given patient is corrected by the ratio between his own age (PA) 
and the mean age within the MMI group of SD: 
P(TCRISD) = TCRISD*(PA/MA+MMI) 
This formula can be used for interval assessments of the general CRI in ING, according to 
the recommended by the WHO age intervals for patient grouping – Table 2.3.  
Analogously, one may assess the specific CRI, related to lethal CVC prediction by the equation  
LCRISD = (FLC+MMI/FLC-MMI)SD/(MA+MMI/MA-MMI)SD 
and its personalized value 
P(LCRISD) = LCRISD*(PA/MA+MMI), 
where FLC+MMI and FLC-MMI are the presented in Table 2.3 lethal CVC rates of patients with 
and without MMI. 
Table 2.4 contains the age interval assessments (compliant with WHO recommendations) of 
the specific CRI in the SD groups. The trend towards increasing the value of the index can 
be clearly followed as a function of the severity of the SD.   
The research conducted, leads to the following conclusions. The CVC prediction during 
emergency surgeries is very important, due to the exceptionally high CVC rate – 45% in the 
investigated patient groups. In its turn, the significantly higher CVC rate among patients with 
MMI proves that it is an independent, important and leading risk factor. In this context, MMI 
determines not only the probability of occurrence, but also the CVC severity: fully nonlethal 
(group A); predominantly nonlethal (groups B, C, D); predominantly lethal (group E).  
The rate trends of the nonlethal (low severity) and lethal (considerable severity) 
complications among patients in the SD groups with and without MMI take into 
consideration the age influence, since it can not be disregarded in risk factor evaluation. 
Therefore, the MMI presence qualitatively determines the following, influenced by the age 
CVC risks:    
- group A (low surgical severity): rare and mild CVC in young patients, who dominate in 
the group; relatively frequent, but mild CVC among the more elderly; 
- group B (relatively low surgical severity): high rate of mild CVC due to the specific high 
mean age;  
- groups C and D (increased surgical severity): increased probability of mild CVC  with 
the age increase; increased probability of high severity CVC  with the SD severity 
increase;   
- group E (considerable surgical severity): high probability of high severity CVC, due to 
the specific high mean age; the risk of mild CVC is identical in patients with and 
without MMI. 
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Age > 18 - 40 41 -55 56 - 65 66 - 75 76 - 90 > 90 
A 1,4 - 3,2 3,2 - 4,3 4,3 - 5,1 5,1 - 5,9 5,9 - 7,1 > 7,1 
B 0,5 - 1,1 1,1 - 1,5 1,5 - 1,8 1,8 - 2,1 2,1 - 2,5 > 2,5 
C 0,4 - 0,95 0,95 - 1,3 1,3 - 1,5 1,5 - 1,8 1,8 - 2,2 > 2,2 
D 0,5 - 1,2 1,2 - 1,7 1,7 - 2,0 2,0 - 2,3 2,3 - 2,7 > 2,7 
E 0,3 - 0,6 0,6 - 0,8 0,8 - 1,0 1,0 - 1,1 1,1 - 1,4 > 1,4 
Table 2.3. Values of TCRI according to surgery groups and age intervals 
 
Age > 18 - 40 41 -55 56 - 65 66 - 75 76 - 90 > 90 
A 0 0 0 0 0 0 
B 0,06 - 0,13 0,13 - 0,18 0,18 - 0,22 0,22 - 0,25 0,25 - 0,30 > 0,30 
C 0,13 - 0,31 0,31 - 0,43 0,43 - 0,50 0,50 - 0,59 0,59 - 0,73 > 0,73 
D 0,22 - 0,53 0,53 - 0,75 0,75 - 0,88 0,88 - 1,01 1,01 - 1,19 > 1,19 
E 0,30 - 0,60 0,60 - 0,80 0,80 - 1,00 1,00 - 1,10 1,10 - 1,40 > 1,40 
Table 2.4. Values of LCRI according to surgery groups and age intervals 
4. Extended quantitative schemes for risk evaluation of perioperative acute 
coronary syndromes and other cardiovascular complications during 
emergency high risky noncardiac surgery 
The proposed, in the preceding paragraph, index for cardiac risk assessment based on the 
ST-depression has to be interpreted as an express method, applied under the specific 
conditions of emergency noncardiac surgery for prediction of acute CVC during the 
postoperative period. The mentioned index is powerful, as it pays attention to manifested 
myocardial ischemia, which is among the proven factors, determining the high cardiac risk 
in patients with MNCS. This concept, combined with the conclusion about the limited 
applicability of the known schemes for CR assessment under  emergency MNCS conditions, 
raises the actual problem related to the synthesis of extended schemes for risk evaluation 
that offer a compromise between the requirement of highly significant assessment and its 
achievement, based on available patient data. Below, we propose such schemes, synthesized 
on the basis of real patient data undergoing emergency abdominal surgery.  
The study uses data obtained by the same 466 patients with emergency treated acute 
surgical abdominal diseases or traumas (see Table 2.1). The data from large sets of indicators 
have been collected. The pilot investigation on the potential contributions of indicators that 
may reliably characterize the CVC, resulted in the constellation shown in Table 3.1. The data 
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cover the three periods of the disease process: preoperative, intraoperative and 
postoperative. Each indicator has its own structure of category-related or quantitative 
values, appropriately coded to be processed through a multidimensional statistical 
approach. We used discriminant analysis (DA) for the synthesis of rules, allowing 
quantitative evaluation of the CVC risk appearance probability, during the intra- and 
postoperative periods. The categorisation of individual patients to the CVC group with a 
given CR level, or to the group without CVC, is performed by substituting the patient’s 
indicators values in the linear discriminator. The patient belongs to the control group if the 
discriminator value is below the limit. Such are the operated patients without perioperative 
CVC, even only with transient CVD or abnormal values of some indicators related to the 
cardiovascular system. Discriminator value above the limit classified the patient to the 
corresponding risk level group. The hypothesis about CVC appearance with higher risk 
level is verified by the next discrimination rule, which assesses the probability of higher risk 
of CVC. 
 
Age Diabetes mellitus 
Surgical conditions Lung breathing 
Volume of surgery Lung auscultatory 
Duration of anesthesia Systolic blood pressure 
Total duration of intubation Diastolic blood pressure 
Intraoperative surgery complications Central venous pressure 
Intraoperative CVC with low risk Heart rate 
Intraoperative CVC with moderate risk   Heart rhythm 
Intraoperative CVC with high risk Heart  auscultatory 
Postoperative surgery complications Hemoglobin 
Postoperative CVC with low risk Glucose 
Postoperative CVC with moderate risk Urea 
Postoperative CVC with high risk Creatinine 
Cause of death, noncardiac Potassium 
Cause of death, cardiac Enzymes - SGOT 
Arterial hypertension,  class Enzymes - SGPT 
Ischemic heart disease X-ray lung 
Myocardial infarction Exercise ECG 
Arrhythmias Myocardial ischemia - preoperative 
Heart failure Myocardial ischemia - intraoperative 
Chronic pulmonary disease  
Table 3.1. Used indicators 
The level of discrimination significance depends on the patient numbers, correctly or 
incorrectly assigned to the training groups. In our case, training groups are the control 
patient group and the groups with specified CR level. The 446 operated persons are 
distributed in training groups, which correspond almost totally to the ACC/AHA 
classification of intra- and postoperative CVC [2, 20]. Two corrections are introduced, since 
the analysis of the false positive and false negative errors in previous own research, 
following strictly the ACC/AHA classification, showed the expedience of these corrections 
in the specific practice with emergency noncardiac surgeries: 
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- the transient hypotension of the intraoperative CVC scheme is re-classified  from low 
risk to moderate risk; 
- the compensated HF of the postoperative CVC scheme is re-classified from high risk to 
moderate risk; the decompensate HF is determined as a high risk complication. 
According to these corrections, the patients are distributed in CVC groups with different CR 
level, as it is shown in Table 3.2 and Table 3.3. The control group consists of 97 patients. The 
intraoperative CVC groups are with: low risk – 42; moderate risk – 206; high risk – 41. The 
postoperative CVC groups are: 1 with low risk; 201 with moderate risk; 40 with high risk (21 
of them with, and 19 without cardiac death). 
Further on, the procedure for optimum discriminator synthesis was applied on the 
already differentiated patient groups. Tables 3.4, 3.5, and 3.6 present the weighting 
discrimination coefficients of the corresponding groups, within the models that determine 
the appearance of the risk of: postoperative CVC, based on data from the preoperative 
period; postoperative CVC based on the pre- and intraoperative data period; 
intraoperative CVC based on data from the preoperative period. The lack of a weighting 
coefficient for a given index in some columns means that the step procedure of the 
discriminant analysis has rejected this index as non-contributing to the correct patient 
distribution in the corresponding groups. 
 
Level of 
risk 
Type of complication 
Number of 
patients 
Low 
Short transient hypertension 
42 Supraventricular extrasystoles 
Ventricular extrasystoles 
Moderate 
Transient hypotension 
206 
Unprovoced prolonged hypotension  ( > 1 hour) 
Prolonged hypertension ( > 1 hour) 
Supraventricular arrhythmias  (atrial fibrillation, 
supraventricular  tachycardia) 
Increased heart rate ( > 120 bpm) 
Sinus bradycardia 
ECG manifestations of myocardial ischemia 
Frequent ventricular extrasystoles 
High 
Hypotension during sudden heart failure 
41 
Ventricular extrasystoles class IV 
Ventricular tachycardia 
Acute myocardial infarction 
Acute cardiogenic pulmonary edema 
Cardiac arrest 
Table 3.2. Intraoperative cardiovascular complications 
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Level of 
risk 
Type of complication 
Number of 
patients 
Low 
Hypotension 
1 Supraventricular extrasystoles 
Ventricular extrasystoles 
Moderate 
Hypertension 
201 
 Supraventricular arrhythmias  (atrial fibrillation, 
supraventricular tachycardia) 
Angina attack 
Increased heart rate ( > 120 bpm) 
Sinus bradycardia 
Ventricular extrasystoles class III 
ECG manifestations of myocardial ischemia 
Compensated heart failure NYHA-FC I - II  
High 
Decompensated heart failure, high NYHA-FC 
40 
Acute cardiogenic pulmonary edema 
Acute myocardial infarction 
Cardiac arrest 
 
 
 
 
Table 3.3. Postoperative cardiovascular complications 
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Indicators 
Discrimination 
CVC with 
moderate 
risk vs. 
control 
group 
CVC 
with high 
risk vs. 
control 
group 
Cardiac 
death vs. 
control 
group 
CVC 
with high 
risk vs. 
cardiac 
death 
CVC with 
moderate 
risk vs. 
CVC with 
high risk 
Age    8.0  
Arterial hypertension 10.5     
Ischemic heart disease 2.5 15.0  14.0 6.5 
Myocardial infarction   18.5 55.5  
Arrhythmias  4.5    
Heart failure 12.0 17.5 57.0 3.5  
Chronic pulmonary disease 8.5     
Diabetes mellitus   3.0 2.0 4.5 
Lung breathing, preoperative  10.0    
Lung auscultatory, preoperative      
Systolic blood pressure, preoperative   0.5   
Diastolic blood pressure, 
preoperative 
     
Central venous pressure, 
preoperative 
    19.5 
Heart rate, preoperative 19.5 6.5 6.0   
Heart rhythm, preoperative      
Heart  auscultatory, preoperative  1.0 4.0  3.0 
Hemoglobin, preoperative 3.0 18.0 11.0  7.0 
Glucose, preoperative 3.5     
Urea, preoperative      
Creatinine, preoperative    13.5 43.5 
Potassium, preoperative      
Enzymes - SGOT, preoperative      
Enzymes - SGPT, preoperative      
X-ray lung, preoperative  27.5  3.5 16.0 
Exercise ECG, preoperative      
Myocardial ischemia - preoperative 40.5     
Limit value for positive test: 40 30 60 35 30 
Table 3.4. Quantitative  models for postoperative CVC risk assessment according to 
preoperative data 
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Indicators 
Discrimination 
CVC with 
moderate 
risk vs. 
control 
group 
CVC with 
high risk 
vs. control 
group 
Cardiac 
death vs. 
control 
group 
CVC with 
high risk 
vs. cardiac 
death 
CVC with 
moderate 
risk vs. 
CVC with 
high risk 
Age      
 Surgical conditions      
Volume of surgery 1.0   8.0  
Duration of anesthesia   2.0   
Intraoperative surgery complications 0.5   5.0  
Intraoperative CVC with low risk 4.5 5.0 3.5   
Intraoperative CVC with moderate risk   81.0 69.0 41.0   
Intraoperative CVC with high risk 8.5 21.5 43.0 8.5  
Arterial hypertension,  class 2.0     
Ischemic heart disease    3.5 5.5 
Myocardial infarction    7.0  
Arrhythmias      
Heart failure    15.5  
Chronic pulmonary disease   1.5   
Diabetes mellitus    7.5 3.5 
Lung breathing, preoperative      
Lung breathing, intraoperative      
Lung auscultatory, preoperative 1.5  1.5   
Lung auscultatory, intraoperative    6.5  
Systolic blood pressure,  preoperative   0.5   
Diastolic blood pressure, preoperative 0.5     
Systolic blood pressure, intraoperative      
Diastolic blood pressure, preoperative      
Central venous pressure , preoperative    3.5 11.5 
Central venous pressure, intraoperative    17.0 15.0 
Heart rate, preoperative   1.0   
Heart rate, intraoperative    9.0  
Heart rhythm, preoperative      
Heart rhythm, intraoperative   5.0   
Heart  auscultatory, preoperative     2.5 
Hemoglobin     4.5 
Glucose      
Urea      
Creatinine    3.5 30.0 
Potassium      
Enzymes - SGOT      
Enzymes - SGPT      
X-ray lung    2.5 12.5 
ECG LVH  0.5 0.5   
Myocardial ischemia - preoperative      
Limit value for positive test: 20 20 55 65 25 
Table 3.5. Quantitative  models for postoperative CVC risk assessment according to pre- and 
intraoperative data 
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Indicators 
Discrimination 
CVC 
with low 
risk vs. 
control 
group 
CVC 
with 
moderat
e risk vs. 
control 
group 
CVC 
with 
high 
risk vs. 
control 
group 
CVC 
with 
moderat
e risk vs. 
CVC 
with low 
risk 
CVC 
with high 
risk vs. 
CVC 
with 
moderate 
risk 
Age 24.0 18.5 7.0 6.0  
Arterial hypertension 22.0 6.5 2.5 9.5  
Ischemic heart disease  5.5 3.0   
Myocardial infarction 11.0  8.0  20.5 
Arrhythmias 42.0   19.5  
Heart failure  12.0 13.0  11.0 
Chronic pulmonary disease  9.0  4.5  
Diabetes mellitus      
Lung breathing, preoperative  8.0 19.0  17.0 
Lung auscultatory, preoperative   8.5   
Systolic blood pressure, 
preoperative 
     
Diastolic blood pressure, preoperative     7.5 
Central venous pressure, 
preoperative 
    10.0 
Heart rate, preoperative  23.5  15.5  
Heart rhythm, preoperative      
Heart  auscultatory, preoperative     8.5 
Hemoglobin, preoperative  2.5 20.5  25.5 
Glucose, preoperative   6.0   
Urea, preoperative      
Creatinine, preoperative      
Potassium, preoperative      
Enzymes - SGOT, preoperative      
Enzymes - SGPT, preoperative      
X-ray lung, preoperative 1.0     
Exercise ECG, preoperative   2.0   
Myocardial ischemia - preoperative  12.5 14.5 45.0  
Limit value for positive test: 90 80 40 60 30 
Table 3.6. Quantitative  models for intraoperative CVC risk assessment according to 
preoperative data 
Tables 3.7 and 3.8 show the results of correct and incorrect classification of patients, on the 
basis of the used training groups, ranged according to the CVC risk. The greater informative 
value of the combination of pre- and intreoperative data for prognosis of postoperative CVC 
becomes obvious, and the more distinct significance for prognosis of each higher-risk level 
of the post- and intraoperative CVC.  
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Table 3.7. Predictive value of models for evaluation of cardiovascular complications 
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Table 3.8. Predictive value of models for evaluation of cardiovascular complications  (in 
patient groups with adjacent levels of cardiac risk) 
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Generally, the proposed models for risk assessment of acute CVC appearances, and of 
incidents with patients undergoing emergency noncardiac interventions, manifest not only 
high significance, but also point out:   
- the importance of the intraoperative CVC (especially that with moderate risk) for 
prognosis of all risk level postoperative CVC, based on preoperative and intraoperative 
data;  
- the obtained discrimination between the groups with cardiac death and high risk 
complications, which is impossible when directly using the ACC/AHA classification of 
intra- and postoperative CVC;  
- certain decrease of the discrimination importance of the preoperatively ECG detected 
myocardial ischemia together with keeping its role in prognosticating the intraoperative 
CVC with moderate and high risk, which are among the factors that determine the rate 
and the severity of the postoperative CVC.    
5. Cardiac risk reduction strategies 
The topical risk assessment of perioperative cardiac incidents during noncardiac surgery, 
attracts the attention of the specialists, and is the reason for permanent updating of the 
practices leading to significant evaluation. It is sufficient to list the handbooks published by 
competent professional societies, including the ESC Guidelines, issued in 2009, on 
preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac 
surgery [61, 62, 63]. The final goal of these strategies for evaluating the cardiac risk and the 
optimization of heart management during noncardiac surgery, based on this evaluation, is the 
reduction of perioperative acute cardiac incidents. The strategies can be summarized, without 
reiteration of the available algorithms, in following three directions. 
5.1 Pharmacological strategy 
Surgeries of patients with moderate and low FC and moderate CR can be performed by 
inclusion of statins and low dose beta-blockers. ACE inhibitors are recommended to be 
introduced before intervention on patients with LV dysfunction (EF less than 40%). 
Continued use of beta-blockers is advised with patients having positive preoperative stress-
tests. The latest cardioprotection concepts recommend the use of cardio-selective beta-1-
blockers without internal simpatico-mimetic activity and long half-life time, e.g. bisopropol. 
The statins induce coronary plaque stabilization. Multiple clinical investigations show the 
positive effect of the perioperative use of statins. 
The inhibition of ACE may prevent myocardial ischemia and LV dysfunction, therefore the 
perioperative treatment with ACE inhibitors is expedient.  
Aspirin is widely taken by patients with IHD, especially after intracoronary stent 
implantation. The apprehension of perioperative hemorrhaging complications often leads to 
suspension of the aspirin in the perioperative period. However, this is related to triplicate 
the risk of heavy cardiac incidents. The aspirin admission has to be interrupted only if the 
bleeding risk exceeds the cardiac benefit.  
5.2 Noninvasive stress-tests 
Patients with one or more cardiac risk factors are advised to be ECG monitored for changes 
in the postoperative period. Noninvasive testing is recommended for patients with 3 or 
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more risk factors. The last can be accomplished during each surgery, depending on the 
change in the perioperative strategy – the intervention type and the anesthetic technique.   
Patients without stress-induced moderate or heavy ischemia (orienting towards single- or 
two-branch coronary disease) can continue with the planned intervention by inclusion of 
statins and low dose beta-blockers. Individual approach is recommended for patients with 
heavy stress-induced ischemia, after discussing the potential benefit of the advised surgery 
in comparison with the bad prognosis. It is necessary to specify the effect of the 
medicamentous therapy and/or coronary revascularization not only in the postoperative 
plan, but also in a long-term plan. 
5.3 Revascularization 
When a life-threatening state, requiring surgical intervention, is combined with ACS, it is 
advisable to give advantage to the surgery. However, a second stage necessities aggressive 
medicamentous therapy and revascularization, according to the NSTEMI and STEMI-ACS 
recommendations. 
ACS without ST-elevations is interpreted as a high risk clinical state, requiring accurate 
diagnosis, risk stratification and revascularization. That means that if no life-threatening 
surgical state is present, advantage has to be given to the diagnosis and the appropriate 
treatment of the unstable angina. The corner-stones of the treatment are the double 
antiaggregating therapy, the beta-blocker and the revascularization.    
The antiaggregation and the anticoagulations have to be carefully appreciated before 
applying to patients with unstable AP and forthcoming surgery state, in order to avoid the 
risk of subsequent enhanced bleeding. Most of the patients with unstable AP need 
interventional revascularization and advantage must be given to metal stents, in order not 
to delay the surgery more than three months. 
The main goal of the prophylactic myocardial revascularization is the prevention of lethal 
perioperative MI. As far as the revascularization may be only partially effective in treatment 
of high risk stenosis, it cannot prevent the rupture of vulnerable plaque during the surgery 
stress. This one is found at least in the half of the perioperative MI cases, and can explain the 
lack of specificity in the stress-imaging methods for infarct-related coronary lesions 
discovery. Patients with previous PCI can be with higher risk during or after noncardiac 
surgery, especially in the cases of unplanned or emergency surgery that follow coronary 
stent setting. The intervention duration and the specificity of the process (malignant tumor, 
vascular aneurism, etc.) have to be adequately balanced against the risk of stent-provoked 
thrombosis during the first year after the implantation of drug emitting stent. Careful 
discussion is recommended in every individual case by a team, including a surgeon, an 
anesthesiologist and a cardiologist.        
Despite the specific strategies for risk reduction, the perioperative CR assessment gives an 
opportunity for optimized control of all cardiovascular risk factors.  
6. Index 
-A- 
ACC/AHA classification for CR assessment during noncardiac surgeries 
acute cardiac inflammatory process  
acute conductive disorders 
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acute cardiovascular complications 
acute heart failure  
acute myocardial infarction 
acute rhythm disorders 
angina pectoris (АP) 
arterial hypertension (AH) 
-C- 
cardiac arrhythmias 
cardiac risk (CR) 
cardiogenic shock 
cardiomyopathies 
cardiovascular complications (CVC) 
CR assessment in emergency noncardiac surgery 
CR assessment schemes in major noncardiac surgery  
CR reduction strategies 
-E- 
ECG manifested myocardial ischemia 
emergency high risky noncardiac surgery 
emergency major surgical interventions 
exacerbated chronic heart failure 
Exceeding Index of the Emergency Surgeries (EIES) 
Exceeding Index of the Major Surgeries (EIMS) 
extended quantitative schemes for CR evaluation 
-F- 
functional class (FC) 
-H- 
heart failure (HF) 
heart valvular disease 
hypertensive crisis 
-I- 
indices for CR evaluation 
intraoperative CVC 
investigated surgical nosological groups (ING) 
ischemic heart disease (IHD) 
-M- 
major noncardiac surgery (MNCS) 
major surgical interventions 
manifested myocardial ischemia (MMI) 
myocardial infarction (MI) 
-N- 
noncardiac surgery 
noncoronary ischemia 
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-P- 
perioperative cardiovascular complications 
perioperative CVC 
peripheral vascular diseases 
preoperative CVC 
-R- 
real and relative myocardial ischemia 
-S- 
scales for CR evaluation 
ST-depression in the preoperative ECG 
sudden cardiac death 
surgical factors in CR 
-T- 
Total Index for CR assessment, through ST-depression in the preoperative ECG (TCRISD) 
-U- 
unstable stenocardia 
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